Cosmo Bio USA offers a highly specialized Cells & Cell Separation product portfolio designed to power cutting-edge research in immunology, stem cell biology, regenerative medicine, and biotherapeutic development. Serumwerk Bernburg leads with trusted clinical-grade separation media—including Lymphoprep™, Polymorphprep™, Nycodenz™, and OptiPrep™—for efficient isolation of mononuclear cells, granulocytes, and small particles like viruses and extracellular vesicles. Cosmo Bio Co., Ltd. enhances this offering with a broad range of primary cells, including mesenchymal stem cells and immune cells, as well as extracellular matrix proteins such as fibronectin and laminin. Their innovative cell separation reagents support improved cell purification, adhesion, and culture performance for reproducible experimental outcomes.
Further elevating the portfolio, Cellular Engineering Technologies (CET) provides human primary cells, iPSCs, and immortalized cell lines produced under xeno-free, defined conditions for translational and regenerative applications. JSR Corporation contributes advanced magnetic bead technologies for gentle, high-efficiency immunomagnetic cell isolation—ideal for cell therapy, rare cell enrichment, and immunology workflows. Tokyo Ohka Kogyo (TOK) rounds out the lineup with the Sieve Well Slide, a precision-engineered microwell array platform enabling high-throughput single-cell capture, imaging, and clonal selection. Together, these rigorously validated solutions reflect Cosmo Bio USA’s commitment to accelerating innovation in cell-based research, supporting breakthroughs in therapeutic development and precision medicine.